Senior insider sale
Chief Executive Officer at AXSOME THERAPEUTICS, INC. — senior position signals high conviction
$12.20M
49.67K shares
What this filing means
TABUTEAU HERRIOT plans to sell 49.67K shares of AXSOME THERAPEUTICS, INC. valued at approximately $12.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/9/2026ACC: 0001958244-26-000358
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2026
49.67K
Shares to sell
$12.20M
Approx. market value
49.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Acquired as compensation -- Stock Options
Compensation -- Cashless exercise / same-day sale
3/15/2017
49.67KTotal acquired49.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2017 | Acquired as compensation -- Stock Options Compensation -- Cashless exercise / same-day sale | 49.67K | — |
| Total | 49.67K | ||
Planned & Completed Dispositions1
NASDPlanned
Units to sell
49.67K
Market value
$12.20M
6/9/2026
Total
Units
49.67K
Value
$12.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/9/2026 | 49.67K | $12.20M | NASD | Planned |
| Total | 49.67K | $12.20M | ||